Fracture disease what's it causes and etiology pathology signs and symptoms and investigations treatment of this explain in detail with appropriate illustrative diagrams and images
fracture disease definition causes pathology signs symptoms treatment orthopedics
https://www.ncbi.nlm.nih.gov/books/NBK559077
https://www.ncbi.nlm.nih.gov/books/NBK559077
Medical educational diagram titled "Fracture Disease (Frakturkrankheit) - Immobilization Syndrome" showing a central image of a fractured limb in a cast, with arrows pointing outward to labeled boxes showing the six main complications: 1. Disuse Osteoporosis (bone thinning with reduced density), 2. Muscle Atrophy (shrunken muscle fibers), 3. Joint Stiffness/Contracture (frozen joint), 4. Edema/Swelling (fluid accumulation), 5. Deep Vein Thrombosis (clot in vein), 6. Complex Regional Pain Syndrome/Dystrophy (Sudeck's atrophy - patchy bone demineralization, skin changes). Clean, professional medical illustration style with labeled arrows and anatomical detail.
Medical diagram showing the pathophysiology cascade of fracture disease: Starting with "FRACTURE + IMMOBILIZATION" at the top, arrows flowing down to "Reduced Mechanical Loading on Bone" leading to "Osteoclast activation > Osteoblast activity" causing "Disuse Osteoporosis". Parallel pathway shows "Muscle inactivity" leading to "Protein catabolism" causing "Muscle Atrophy". Another branch shows "Reduced joint movement" leading to "Synovial fibrosis and capsular contracture" causing "Joint Contracture". Bottom shows "Autonomic Nervous System Dysregulation" leading to "Vasomotor instability, edema, trophic changes" labeled as "Algodystrophy/CRPS". Clean flowchart style, medical textbook quality.
Medical radiology comparison diagram showing X-ray appearance of fracture disease complications: Left panel labeled "Normal Bone" showing dense, well-defined cortical and trabecular bone. Right panel labeled "Disuse Osteoporosis (Sudeck's Atrophy)" showing patchy/mottled demineralization, thinned cortex, sparse trabeculae - characteristic spotty osteoporosis pattern. Center panel showing clinical photo of limb with fracture disease showing shiny, atrophic skin, swelling, and color changes. Labels pointing to key radiological features: cortical thinning, endosteal scalloping, periarticular demineralization. Medical textbook illustration style.
Edema + Muscle Atrophy + Dystrophy (algodystrophy/CRPS)

| Cause | Mechanism |
|---|---|
| Fracture treated with cast/plaster | Rigid immobilization prevents all movement |
| Fracture treated conservatively | Prolonged bed rest or splinting |
| Post-surgical immobilization | Rest after internal fixation before mobilization begins |
| Soft-tissue injury with immobilization | Sprains, dislocations kept immobile |
| Neurological injury co-existing with fracture | Paralysis compounds disuse |
From General Anatomy and Musculoskeletal System (THIEME Atlas): "Immediate mobilization prevents thrombosis, emboli, decubitus, and fracture disease, e.g., edema and dystrophy."

From Rockwood and Green's Fractures in Adults (10th ed., 2025): "CRPS refers to an unexplained pain syndrome...characterized by disproportionate pain and accompanying autonomic and motor disturbances...Nowadays it is considered a rare, devastating complication of minor injury caused by disuse and seen in any patient at every age."
| Category | Symptoms (Reported) | Signs (Observed on Exam) |
|---|---|---|
| Pain | Burning, disproportionate pain; allodynia; hyperesthesia | Hyperalgesia to pinprick; allodynia to light touch |
| Vasomotor | Skin color changes; temperature difference between limbs | Temperature asymmetry >1°C; skin color/asymmetry |
| Edema/Sudomotor | Swelling; increased/decreased sweating | Pitting or non-pitting edema; sweating asymmetry |
| Motor/Trophic | Weakness; reduced range of motion; tremor | Muscle wasting; joint stiffness; dystonia; trophic changes (nails, hair, skin) |

| Test | Relevance |
|---|---|
| Full blood count (FBC) | Baseline; infection screen |
| ESR/CRP | Elevated in inflammatory phase of CRPS |
| Serum calcium, phosphate, ALP | Bone metabolism markers |
| Serum D-dimer | Screening for DVT/PE |
| Urine calcium | Increased in disuse osteoporosis (hypercalciuria) |
| Urinalysis | Kidney stones (from hypercalciuria) |
The best treatment is prevention through early mobilization after fracture stabilization.
| Modality | Details |
|---|---|
| Physical Therapy | Graded exposure, pain exposure physical therapy (PEPT), desensitization; KEY treatment |
| Analgesics | NSAIDs, paracetamol for mild; tramadol/opioids for severe |
| Neuropathic agents | Gabapentin, pregabalin for neuropathic pain |
| Corticosteroids | Short course in acute phase (prednisolone) |
| Bisphosphonates | Pamidronate, alendronate - reduce bone pain and osteoporosis |
| Calcitonin | Analgesic + antiresorptive effect (intranasal or injection) |
| Sympathetic nerve block | Stellate ganglion / lumbar sympathetic block - provides temporary relief |
| Spinal cord stimulation | For chronic refractory CRPS - reduces pain via dorsal column modulation |
| Psychological therapy | CBT, exposure in vivo, graded motor imagery - addresses kinesiophobia |
| TENS | Transcutaneous electrical nerve stimulation for pain relief |
| Mannitol IV | Free radical scavenger - used in acute severe CRPS |
| Vitamin C | 500 mg/day post-fracture shown to reduce CRPS incidence (particularly wrist fractures) |
| Amputation | Last resort in severe intractable cases with severe tissue destruction |
From Rockwood and Green's Fractures in Adults: "After the introduction of several more cognitive and behavioral treatment methods, such as pain exposure physical therapy (PEPT) and exposure in vivo, it appeared that disuse and kinesiophobia played an important role in the development and maintenance of CRPS."
| Outcome Factor | Better Prognosis | Worse Prognosis |
|---|---|---|
| Duration of immobilization | Short | Long (>6 weeks) |
| Age | Young | Elderly |
| Stage of CRPS at diagnosis | Stage 1 (acute) | Stage 3 (atrophic) |
| Treatment approach | Early, multidisciplinary | Delayed, unimodal |
| Patient compliance | Good | Poor (kinesiophobia) |
| Co-morbidities | None | Diabetes, vascular disease |
FRACTURE + PROLONGED IMMOBILIZATION
|
┌──────┴──────────────────────────────┐
| |
LOCAL EFFECTS SYSTEMIC EFFECTS
| |
┌──┴────────────────────┐ DVT / PE
| | |
Disuse Muscle Joint
Osteo- Atrophy Stiffness
porosis /Contracture
|
Sudeck's Atrophy
(CRPS - Algodystrophy)
|
├─ Pain (burning, disproportionate)
├─ Vasomotor changes (color, temperature)
├─ Edema + Sweating abnormalities
└─ Motor/Trophic changes
TREATMENT:
Prevention > Early mobilization after osteosynthesis
Rehabilitation > Physiotherapy, PEPT, graded exposure
Pharmacology > Bisphosphonates, Ca/Vit D, neuropathics
Intervention > Sympathetic blocks, SCS, surgery